Skip to content
feel20
GLP-1 receptor agonistGLP-1 anchor

Semaglutide

a GLP-1 receptor agonist

A GLP-1 receptor agonist that copies a hormone your gut releases after you eat — the signal that tells your brain you're satisfied and helps your body manage blood sugar.

What it's studied for

Semaglutide is studied for its effect on appetite signaling, how quickly the stomach empties, and blood-sugar regulation. It is among the most-studied molecules in modern metabolic medicine. We describe how it's studied to work — not a result you'll personally get — and a US-licensed provider decides whether it's appropriate for you.

Free 5-minute check · Pay only if a provider prescribes · From $199/month

GLP-1 Weight Care

The mechanism

How Semaglutide is studied to work.

Semaglutide mimics GLP-1, a hormone your gut releases after a meal. Instead of forcing an effect, it speaks a language your body already uses — which is why a provider doses it gradually.

1

Quiets the food noise

Acts on the brain's hunger and fullness centers — the same circuitry your own gut hormone speaks to after eating — so the constant pull toward food is studied to get quieter.

2

Slows gastric emptying

Slows how quickly the stomach empties, so a normal-sized meal is studied to register as enough and that fullness holds longer.

3

Supports steadier blood sugar

Supports glucose-dependent insulin release and lowers glucagon, which is studied to help smooth the spikes and dips that drive cravings.

4

Titrated by your provider

Treatment begins low and is adjusted by your provider over time to balance how you feel against side effects. You never raise the dose yourself.

How it's typically delivered: Typically a once-weekly self-administered injection, started low and titrated upward over time by your provider. The exact dose and schedule are determined by your provider — never by you.

Where it comes from

Quality & sourcing.

If a provider prescribes a compounded semaglutide, it is prepared by a state-licensed US compounding pharmacy and cold-shipped to your door. Compounded medications are not FDA-approved, though the pharmacies that prepare them are licensed and regulated — we say that up front, not in fine print.

State-licensed compounding pharmacy

Prescriptions are filled by state-licensed US compounding pharmacies operating under state board oversight — not gray-market suppliers.

503A & 503B framework

Compounding is handled under the 503A and 503B framework that governs US compounding pharmacies, with state board and applicable federal oversight.

Cold-chain handling

This is a temperature-sensitive medication, so it ships cold in plain, discreet packaging to stay stable from the pharmacy to your door.

Certificate of analysis on request

Where a pharmacy provides one, a certificate of analysis (COA) for a compounded preparation can be requested through your care team.

The FDA caveat, said out loud: Compounded medications are not FDA-approved, though the pharmacies that prepare them are licensed and regulated. We tell you up front, not in fine print.

Want to know if it's a fit for you?

A US-licensed provider reviews whether Semaglutide is appropriate for you. The check is free and takes about 5 minutes — you pay only if a provider prescribes.

Start your free eligibility check

The honest safety picture.

GLP-1 medications can cause side effects, most commonly when starting or raising a dose. They aren't right for everyone. Your provider reviews your full history and the complete safety information before prescribing, and monitors how you respond.

Individual results vary. We describe how Semaglutide is studied to work — never a result you'll personally get — and a provider reviews the full safety information with you before any prescription.

Common side effects
Most commonly nausea, constipation, or fatigue, especially when starting or increasing a dose. Starting low and adjusting slowly is studied to help manage them.
Serious risks to know
Rarer but serious risks matter too. In rodent studies, GLP-1 medicines caused thyroid C-cell tumors, so they aren't recommended if you or a close family member has had medullary thyroid carcinoma or MEN 2. Other risks include pancreatitis, gallbladder problems, and low blood sugar if combined with insulin or a sulfonylurea. They aren't for use during pregnancy. Your provider screens for all of this before anything is prescribed.
Tell your provider everything
Share your complete health history and current medications during your consultation. The more your provider knows, the safer your care.
A provider stays involved
Your care team checks in and adjusts — or pauses — treatment based on how your body responds. This is monitored care, not a refill you chase down.

Not for everyone — a provider decides.

Semaglutide isn't right for everyone. Providers generally consider your history, current medications, and whether GLP-1 therapy fits your goals — and a real percentage of people are told no. If a provider decides it isn't appropriate, you'll hear that honestly. You pay only if a provider prescribes treatment, and any payment is fully refunded if treatment later isn't right for you.

  • No prescription is written without a US-licensed provider reviewing your history
  • Told no? You pay nothing — the check is free

Curious if Semaglutide is right for you?

The eligibility check is free, takes 5 minutes, and a real provider decides which molecule — if any — is right for your body.

Start your free eligibility check

Free to apply · Prescription only if a licensed provider approves · Cancel anytime